Bito T, Ueda M, Nagano T, Fujii S, Ichihashi M
Department of Dermatology, Kobe University School of Medicine, Japan.
Photodermatol Photoimmunol Photomed. 1995 Feb;11(1):9-13. doi: 10.1111/j.1600-0781.1995.tb00130.x.
Ultraviolet (UV) irradiation produces two major photoproducts, cyclobutane pyrimidine dimers (CPD) and (6-4) photoproducts. T4 endonuclease V (T4N5), which specifically repairs CPD, is encapsulated in liposomes. A previous study has shown that UV-induced carcinogenesis in mice was suppressed by the application of T4N5 liposomes. To confirm the suppressive effect, we applied T4N5 liposomes with repeated UVB exposure to hairless mice. At the end of the experiment, mice treated with T4N5 liposomes had 3.5 +/- 1.3 tumors per mouse, and control mice had 6.3 +/- 2.8 tumors per mouse. In addition, the incidence of tumors was reduced in T4N5 liposome-treated mice compared with controls. The pathological diagnosis of the tumors was not significantly different between two groups. Immunohistochemical analysis of p53 protein in UV-induced tumors showed that nearly half of the tumors in both groups were positive. When the biopsied normal-looking skin taken during the experiment was stained with p53 antibody, there was no significant difference of the timing of p53 protein expression between the control mice and T4N5 liposome-treated mice. These results confirmed that CPD plays a pivotal role in UV carcinogenesis, although the molecular mechanisms of the suppression by T4N5 liposomes should be further clarified.
紫外线(UV)照射会产生两种主要的光产物,即环丁烷嘧啶二聚体(CPD)和(6-4)光产物。特异性修复CPD的T4内切核酸酶V(T4N5)被包裹在脂质体中。先前的一项研究表明,应用T4N5脂质体可抑制小鼠紫外线诱导的致癌作用。为了证实这种抑制作用,我们将T4N5脂质体应用于反复接受UVB照射的无毛小鼠。在实验结束时,接受T4N5脂质体治疗的小鼠每只小鼠有3.5±1.3个肿瘤,而对照小鼠每只小鼠有6.3±2.8个肿瘤。此外,与对照组相比,T4N5脂质体治疗的小鼠肿瘤发生率降低。两组肿瘤的病理诊断没有显著差异。对紫外线诱导肿瘤中p53蛋白的免疫组织化学分析表明,两组中近一半的肿瘤呈阳性。当用p53抗体对实验期间采集的外观正常的活检皮肤进行染色时,对照小鼠和T4N5脂质体治疗的小鼠之间p53蛋白表达的时间没有显著差异。这些结果证实CPD在紫外线致癌作用中起关键作用,尽管T4N5脂质体抑制作用的分子机制仍需进一步阐明。